Concert Genetics
Glenn Nelson is a seasoned software engineer with extensive experience in developing and migrating software applications across various technologies. Currently serving as a Senior Software Engineer at Concert Genetics, Glenn manages third-party penetration testing and addresses system vulnerabilities. Previous roles include Senior Software Engineer at Charleston Water System, where Glenn migrated billing and internal tooling from Java/PowerBuilder to C#/Angular, and Software Engineer at Thesys Technologies, LLC, focused on re-engineering front-end applications for high-frequency trading. Additional experience at PhishLabs involved creating security case management tools and leading remote teams, while earlier positions included developing a consumer-facing SaaS at Echovate and building content management systems at BiblioLabs using various frameworks and technologies.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.